Arcus Biosciences Inc. (RCUS)
undefined
undefined%
At close: undefined
16.08
-0.19%
After-hours Dec 13, 2024, 07:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -307.00M -267.00M 52.83M -122.86M -84.71M -49.59M -53.08M -17.97M
Depreciation & Amortization 8.00M 6.00M 3.84M 4.19M 3.58M 3.66M 2.61M 1.31M
Stock-Based Compensation 73.00M 65.00M 55.00M 22.00M 8.98M 3.87M 495.00K 90.00K
Other Working Capital -85.00M 615.00M -367.88M 178.38M -2.54M 1.40M 24.86M 53.00K
Other Non-Cash Items -9.00M 11.00M 3.47M -46.00K -1.44M -177.00K -98.00K 90.00K
Deferred Income Tax - - 4.77M - - -2.10M 416.00K -90.00K
Change in Working Capital -71.00M 623.00M -375.62M 208.06M 125.00K 1.33M 24.60M 3.62M
Operating Cash Flow -306.00M 438.00M -256.17M 111.17M -73.46M -43.00M -25.06M -12.94M
Capital Expenditures -24.00M -12.00M -26.08M -3.06M -1.93M -3.74M -5.51M -4.10M
Acquisitions - - -22.00M 431.00M -61.14M - - -1.00M
Purchase of Investments -788.00M -1.24B -718.87M -739.66M -247.75M -261.55M -96.83M -33.76M
Sales Maturities Of Investments 1.01B 837.00M 741.08M 308.35M 308.89M 151.85M 53.27M 1.00M
Other Investing Acitivies - 3.00M 22.00M -431.00M 61.14M -109.70M -43.56M -1.00M
Investing Cash Flow 194.00M -413.00M -3.87M -434.37M 59.21M -113.44M -49.07M -38.86M
Debt Repayment - - 5.00M - - - - -
Common Stock Repurchased - - -6.00K -54.00K -94.00K - - -
Dividend Paid - - - - - - - -
Other Financial Acitivies 8.00M 33.00M 12.34M 4.67M 1.22M 3.96M 107.40M 70.10M
Financial Cash Flow 33.00M 33.00M 237.34M 438.68M 1.12M 129.07M 107.40M 70.10M
Net Cash Flow -79.00M 58.00M -22.70M 115.48M -13.13M -27.36M 33.27M 18.30M
Free Cash Flow -330.00M 426.00M -282.25M 108.11M -75.39M -46.74M -30.57M -17.04M